Overview
SOPHiA DDM™ is an AI-driven, cloud-powered software-as-a-service (SaaS) platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders. The platform analyzes complex genomic, radiomic, and multimodal data, converting it into insights to reshape how cancer and rare inherited disorders are diagnosed and treated. SOPHiA GENETICS aims to democratize data-driven medicine by providing AI-powered solutions that accelerate healthcare innovation and research globally.
The platform was initially designed as a research tool for hospitals and federally regulated healthcare labs and later expanded to biopharma institutions. It helps interpret circulating tumor DNA and circulating tumor cells in various liquid samples. SOPHiA DDM™ uses machine learning to organize and interpret complex biomedical data, assisting researchers in prioritizing signals, connecting evidence, and transforming raw data into structured research inputs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI/machine learning-powered algorithms for accurate data analysis
- Cloud-based SaaS platform
- Analysis of genomic, radiomic, and multimodal data
- Pseudonymization, anonymization, minimization, and segregation of data
- Strict access control and end-to-end encryption
- Variant calling and annotation
- Exploration and interpretation tools
- Reporting functionalities
- Universal compatibility with existing workflows and technologies
- Scalable infrastructure with NVIDIA GPUs
Use Cases
- Oncology (Solid Tumors, Blood Cancers, Hereditary Cancers, Liquid Biopsy)
- Rare and Inherited Disorders
- Biomarker discovery and clinical trial assays
- Companion diagnostic development and deployment
- Pharmacogenomics
- Carrier screening
Details
| Category | Clinical Decision Support & Reference |
| Pricing | Paid — Unit-based pricing; Education pricing available |
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status |
Unknown SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use should be obtained by contacting the company. |
| Integrations | |
| EHR | Not specified |
| Specialties | All specialties |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate SOPHiA DDM
Videos
Product demos, reviews, and walkthroughs for SOPHiA DDM.
No FAQs available yet for this tool.
Investors who backed SOPHiA DDM
Funded through the company that built this tool.
